| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/21/2011 | CN102188691A Application of tachyplesin in preparing antihrombotic medicines and health-care products and preparation method thereof |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188645A Medicament for treating ascites and preparation method thereof |
| 09/21/2011 | CN102188636A Bamboo shoot extract with function of improving anemia, preparation method thereof and compound preparation thereof |
| 09/21/2011 | CN102188607A Pharmaceutical composition for treating aplastic anemia |
| 09/21/2011 | CN102188592A Medicine for treating thrombocytopenia after tumor chemotherapy and preparation method thereof |
| 09/21/2011 | CN102188445A Compound preparation of aminophylline, and preparation method thereof |
| 09/21/2011 | CN102188437A Glycerol fructose injection and preparation method thereof |
| 09/21/2011 | CN102188416A Medicine controlling and curing chronic aplastic anemia |
| 09/21/2011 | CN102188413A Application of tert-butyl hydroquinone in preparing medicament for treating thalassemia |
| 09/21/2011 | CN102188399A Torasemide gastric-floating tablet and preparation method thereof |
| 09/21/2011 | CN101869609B Qi-blood tonifying medicament and preparation method and application thereof |
| 09/21/2011 | CN101791302B Medicinal composition containing sodium ferulate and preparation method thereof |
| 09/21/2011 | CN101690759B Health product for improving nutritional anemia and preparation method thereof |
| 09/21/2011 | CN101343250B Thrombopoietin mimetics |
| 09/21/2011 | CN101301430B Decoction for treating blood deficiency type neurasthenic |
| 09/21/2011 | CN101301428B Oral Chinese medicine for treating pyelonephritis with hematuria |
| 09/21/2011 | CN101301340B Oral Chinese medicine for treating colonitis induced hematochezia |
| 09/21/2011 | CN101301337B Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis |
| 09/21/2011 | CN101283783B Edible health collocryst and its preparation method |
| 09/21/2011 | CN101249149B Pharmaceutical combination for intestinal tract hemostasia and method of preparing the same |
| 09/20/2011 | US8022191 PEG-conjugated erythropoietin |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8022031 Liquid composition of factor VII polypeptides |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021660 Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | CA2699334C Dialysis cartridges comprising sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 09/20/2011 | CA2560523C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels |
| 09/20/2011 | CA2504377C Pharmaceutical preparation of recombinant factor viii lyophilized without albumin as a stabilizer |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2417904C Compounds acting as melanocortin receptor ligands |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2376485C Recombinant anti-cd40 antibody and uses thereof |
| 09/15/2011 | WO2011113036A2 Compositions and methods for expanding bfu-e cells |
| 09/15/2011 | WO2011112838A2 Composition and method for treatment of vascular hyperpermeability |
| 09/15/2011 | WO2011112791A1 Modulating aquaporins with relaxin |
| 09/15/2011 | WO2011112549A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011110876A1 Novel salts for the manufacture of pharmaceutical compositions |
| 09/15/2011 | US20110224292 Method and apparatus for determining anticoagulant therapy factors |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224259 Novel inhibitors |
| 09/15/2011 | US20110224254 Novel inhibitors |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224226 Compositions and methods for increasing blood platelet levels in humans |
| 09/15/2011 | US20110224215 Pre-surgical treatment |
| 09/15/2011 | US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 09/15/2011 | US20110224160 Use of Escin for Treatment of Type IV Hypersensitivity Reaction |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223243 Artificial oxygen carriers and use thereof |
| 09/15/2011 | US20110223230 Hydrogel formulations |
| 09/15/2011 | US20110223229 Immobilised biological entities |
| 09/15/2011 | US20110223216 Nanoparticles and Porous Particles and Methods of Making the Same |
| 09/15/2011 | US20110223211 Pharmaceutical formulations containing irbesartan |
| 09/15/2011 | US20110223210 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 09/15/2011 | US20110223190 Methods for the administration of FV and related compositions |
| 09/15/2011 | US20110223151 Conjugated proteins with prolonged in vivo efficacy |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2791741A1 Modulating aquaporins with relaxin |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364165A2 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents |
| 09/14/2011 | EP2364086A1 Novel antithrombotic diadenosine tetraphosphates and related analogs |
| 09/14/2011 | EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/14/2011 | EP1358215B1 Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1954825B Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 09/14/2011 | CN1872879B Anagonism active polypeptide of CXCR4 acceptor from inflammation protein of virus macrophage |
| 09/14/2011 | CN102186882A Treatment of thrombocytopenia |
| 09/14/2011 | CN102186843A A process for preparation of rosuvastatin acetonide calcium |
| 09/14/2011 | CN102183665A Method and apparatus for monitoring anti-platelet agents |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102180987A Method for extracting corncob polysaccharide |
| 09/14/2011 | CN102180973A Target multifunctional anti-embolism fusion protein as well as preparation method and application thereof |
| 09/14/2011 | CN102180944A Remodeling and glycoconjugation of peptides |
| 09/14/2011 | CN102180890A Cefathiamidine hydrate and preparation method and application thereof |
| 09/14/2011 | CN102178977A Preparation with double functions of stopping bleeding and sustainedly releasing granulocyte colony stimulating factor and preparation method thereof |
| 09/14/2011 | CN102178929A Application of ancylostoma caninum anticoagulant peptide (AcAP) and recombinant thereof in preparation of thrombus dissolving medicaments |
| 09/14/2011 | CN102178905A Chinese medicine body surface application therapeutic technology and Chinese medicine combinations |
| 09/14/2011 | CN102178846A Medicament for rapidly dredging collaterals and eliminating stasis and preparation method thereof |
| 09/14/2011 | CN102178839A Pharmaceutical composition for treating blood deficiency and preparation method thereof |
| 09/14/2011 | CN102178822A Application of garlic oil (GO) in preparing medicament against leucopenia caused by tumor chemo-radiotherapy |
| 09/14/2011 | CN102178812A Medicine for hemostasis and preparation method thereof |
| 09/14/2011 | CN102178783A Blood enriching effervescent tablet formulation and preparation method thereof |
| 09/14/2011 | CN102178776A Formula of blood enriching and activating health paste and preparation method thereof |
| 09/14/2011 | CN102178763A Medicament for treating anaphylactoid purpura |
| 09/14/2011 | CN102178762A Formula of effervescent tablets for invigorating blood circulation and preparation method thereof |
| 09/14/2011 | CN102178745A Decumbent corydalis tuber vacuum freeze drying process and preparation process for decumbent corydalis tuber powder |
| 09/14/2011 | CN102178725A Melilotus officinalis total saponin, preparation method thereof and medicinal application |
| 09/14/2011 | CN102178722A Persimmon leaf general flavone sustained-release micropills and preparation method thereof |